Free Trial
→ An $8 trillion-dollar discovery 17,000 ft underwater (From Porter & Company) (Ad)tc pixel

EKF Diagnostics (LON:EKF) Trading Down 7% - What's Next?

Written by MarketBeat
October 25, 2025
EKF Diagnostics logo with Medical background

Key Points

  • EKF Diagnostics Holdings plc experienced a significant drop of 7% in its stock price on Friday, closing at GBX 26 ($0.35) after trading as low as GBX 23.60 ($0.31).
  • Trading volume surged to approximately 2.28 million shares, which is an increase of 404% compared to the average daily volume.
  • The company reported earnings of GBX 0.43 per share last quarter, with analysts predicting an annual EPS of approximately 2.30.
  • Five stocks to consider instead of EKF Diagnostics.

Shares of EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) dropped 7% on Friday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares were traded during trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of £116.76 million, a P/E ratio of 19.26 and a beta of 0.57. The firm has a 50-day moving average of GBX 29.26 and a two-hundred day moving average of GBX 26.56.

EKF Diagnostics (LON:EKF - Get Free Report) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 earnings per share for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EKF Diagnostics Right Now?

Before you consider EKF Diagnostics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.

While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover
Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.